Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis

BACKGROUND: Metformin is a first-line oral agent used in the treatment of type 2 diabetes, but glycaemic response to this drug is highly variable. Understanding the genetic contribution to metformin response might increase the possibility of personalising metformin treatment. We aimed to establish t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Kaixin, Donnelly, Louise, Yang, Jian, Li, Miaoxin, Deshmukh, Harshal, Van Zuydam, Natalie, Ahlqvist, Emma, Spencer, Chris C, Groop, Leif, Morris, Andrew D, Colhoun, Helen M, Sham, Pak C, McCarthy, Mark I, Palmer, Colin N A, Pearson, Ewan R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Lancet, Diabetes & Endocrinology 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038749/
https://www.ncbi.nlm.nih.gov/pubmed/24731673
http://dx.doi.org/10.1016/S2213-8587(14)70050-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038749/
https://www.ncbi.nlm.nih.gov/pubmed/24731673
http://dx.doi.org/10.1016/S2213-8587(14)70050-6

Ejemplares similares